Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $4.02 Million - $4.65 Million
59,776 New
59,776 $4.6 Million
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $854,441 - $942,184
-20,891 Reduced 96.1%
848 $38,000
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $3.27 Million - $3.64 Million
-79,320 Reduced 78.49%
21,739 $943,000
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $2.39 Million - $2.74 Million
62,006 Added 158.77%
101,059 $4.32 Million
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $763,101 - $858,300
21,636 Added 124.22%
39,053 $1.51 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $3.31 Million - $4.19 Million
-99,916 Reduced 85.16%
17,417 $626,000
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $4.04 Million - $4.95 Million
117,333 New
117,333 $4.48 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $35,226 - $41,449
-1,073 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $28,799 - $36,825
1,073 New
1,073 $35,000
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $209,865 - $237,681
-8,328 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $164,109 - $197,276
6,620 Added 387.59%
8,328 $206,000
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $44,852 - $49,822
1,708
1,708 $50,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $132B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.